findmyKOL
Clinical trialNCT05651828RecruitingEarly phase 1Interventional

Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma

SponsorH. Lee Moffitt Cancer Center and Research InstituteEnrollment34Advanced Basal Cell Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Moffitt Cancer Center

    Tampa, Florida, United States

    Ahmad Tarhini, MD, PhDAndrew Brohl, MDNikhil Khushalani, MDZeynep Eroglu, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Mar 2023
Primary completion
31 Dec 2028
Completion
31 Dec 2029
Last update posted
1 Apr 2026
Registered enrollment
34
Registry id
NCT05651828
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.